Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Octave Bioscience closes $14mm Series A round

Executive Summary

Neurodegenerative disease-focused Octave Bioscience Inc. (biological, clinical, and economic data metrics combined with analytics tools to study disease) closed a $14mm Series A round led by BCBS Venture Partners, with participation from Echo Health Ventures (a collaboration between Cambia Health Solutions and Mosaic Health Solutions), Section 32 (adds a board member), and other new and existing private investors.
Deal Industry
  • Biotechnology
  • Digital Health
  • In Vitro Diagnostics
    • Molecular Diagnostics & Genetic Testing
  • Medical Devices
    • Diagnostic Equipment & Supplies
    • Diagnostic Imaging Equipment & Supplies
      • MRI, NMR
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement

Related Companies